IP Library › Granted Patent US 10,293,008
Granted Patent B2
US 10,293,008 · App. 15/622,616 · Granted May 21, 2019

Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof

Inventors: Muhammed Majeed (Edison, NJ); Kalyanam Nagabhushanam (East Windsor, NJ); Sivakumar Arumugam (Bangalore, IN); Furqan Ali (Bangalore, IN)
Assignee: SAMI LABS LIMITED
A61K35/742A61K36/45A61K36/47A61K36/48A61K36/55A61K36/68A61K36/815A61K36/889A61K36/9068A61P5/50C12N1/20C12P7/6409A61K2035/115Y02A50/473
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,293,008
App. No.
15/622,616
Granted
May 21, 2019
Kind
B2
Abstract

Disclosed herein is (i) a method related to the growth promotional activity of plant based fibers on Bacillus coagulans MTCC 5856; (ii) the combination of plant based fibers and Bacillus coagulans MTCC 5856 to inhibit Gram Negative pathogenic bacteria; and (iii) the production of short chain fatty acids (SCFA) by Bacillus coagulans MTCC 5856 using plant based fibers.

Claims (13)

1. A method comprising co-culturing Bacillus coagulans MTCC 5856 with plant fibers selected from the group consisting of Trigonella foenum - graecum (fenugreek) seed fibers, Lycium barbarum seed fibers, Linum usitatissimum (Flax) seed fibers, Cocos nucifera (Coconut) fibers, Zingiber officinale (Ginger) rhizome fibers, Emblica officinalis (Amla) fruit fibers, Plantago ovata ( Psyllium ) fibers, and Vaccinium oxycoccos (Cranberry) seed fibers.

2. The method according to claim 1 , wherein the viable colony count of Bacillus coagulans MTCC 5856 is increased by the co-culturing compared to Bacillus coagulans MTCC 5856 cultured in the absence of the plant fibers.

3. The method according to claim 1 , further comprising producing a composition comprising the Bacillus coagulans MTCC 5856 and the plant fibers.

4. A method of inhibiting pathogenic Gram Negative bacteria, comprising:

obtaining a composition that was produced by co-culturing Bacillus coagulans MTCC 5856 with plant fibers selected from the group consisting of Trigonella foenum - graecum (fenugreek) seed fibers, Lycium barbarum seed fibers, Linum usitatissimum (Flax) seed fibers, Cocos mucifera (Coconut) fibers, Zingiber officinale (Ginger) rhizome fibers, Emblica officinalis (Amla) fruit fibers, Plantago ovata ( Psyllium ) fibers, and Vaccinium oxycoccos (Cranberry) seed fibers; and

contacting the pathogenic Gram Negative bacteria with the obtained composition to inhibit the pathogenic Gram Negative bacteria.

5. The method according to claim 4 , wherein the pathogenic Gram Negative bacteria is E. coli.

6. The method according to claim 1 , wherein the co-culturing is performed under fermenting conditions to produce short chain fatty acids.

7. The method according to claim 6 , wherein the short chain fatty acids are one or more selected from the group consisting of acetic acid, propionic acid, and butyric acid.

8. The method according to claim 6 , wherein the Bacillus coagulans MTCC 5856 and the plant fibers are fermented under anaerobic conditions.

9. A method for treatment and/or prophylaxis of diet-induced obesity and/or insulin resistance, comprising:

obtaining a composition that was produced by co-culturing Bacillus coagulans MTCC 5856 with plant fibers selected from the group consisting of Trigonella foenum - graecum (fenugreek) seed fibers, Lycium barbarum seed fibers, Linum usitatissimum (Flax) seed fibers, Cocos nucifera (Coconut) fibers, Zingiber officinale (Ginaer) rhizome fibers, Emblica officinalis (Amla) fruit fibers, Plantago ovata ( Psyllium ) fibers, and Vaccinium oxycoccos (Cranberry) seed fibers; and

administering an effective amount of the obtained composition to a subject in need of treatment and/or prophylaxis of diet-induced obesity and/or insulin resistance.

Continuity (4)
Continuation 14839923 · Aug 29, 2015
Provisional Application 62043599 · Aug 29, 2014
Provisional Application 62063453 · Oct 14, 2014
Related Publication 20170274023A1 · Sep 28, 2017